News Archives

News Archives

Avivagen Announces Proposed Extension of Warrants

Ottawa, ON / Business Wire/ October 15, 2019/ – Avivagen Inc. (TSXV:VIV) (“Avivagen” or the “Corporation”), a life sciences corporation focused on developing and commercializing products for livestock, companion animal and human applications that safely support immune function, promote general health and performance, today announced that it will be requesting approval from the TSX Venture …Read More

Avivagen Announces First Order for OxC-beta™ Livestock in Taiwan

Ottawa, ON / BusinessWire/ October 8, 2019/ – Avivagen Inc. (TSXV:VIV) (“Avivagen” or the “Corporation”), a life sciences corporation focused on developing and commercializing products for livestock, companion animal and human applications that safely support immune function, promote general health and performance, is pleased to announce that it has received its first order for OxC-beta™ …Read More

Avivagen Inc. Announces Results for the Third Quarter Ending July 31, 2019

Ottawa, ON /Business Wire/ September 9, 2019 / – Avivagen Inc. (TSXV:VIV) (“Avivagen” or the “Corporation”), a world leader in natural alternatives to antibiotics with its OxC-beta™  technology, announces its unaudited financial results for the third quarter of 2019. For the three-month period ended July 31, 2019, the Corporation reported revenues of $12,484, a decrease …Read More

Demand for OxC-beta™ Livestock Continues to Grow as Avivagen Secures Another Order in Asia-Pacific

Ottawa, ON /Business Wire/ August 26, 2019 / Avivagen Inc. (TSXV:VIV) (“Avivagen”) has secured a new order for two metric tons of OxC-betaTM Livestock (“OxC-beta”) from UNAHCO, its partner in the Philippines. The new order marks the third multi-metric ton order of OxC-betaTM  Livestock by UNAHCO in the past 10 months, helping the company meet …Read More

Avivagen Announces Approval for OxC-beta™ Livestock (“OxC-beta”) in Mexico

Avivagen Inc. (TSXV:VIV) is pleased to announce that it has received approval for OxC-beta™ Livestock (“OxC-beta”) in Mexico.

Avivagen Director Aubrey Dan Named Member of the Order of Canada

Ottawa, ON and Toronto, ON / Business Wire / July 23, 2019/ Avivagen (TSXV:VIV) (“Avivagen” or the Corporation), a life sciences innovation company with a series of patent protected products that support and optimize human and animal health, is pleased to announce that Mr. Aubrey Dan has been named a Member of the Order of …Read More